Stock Updates

How has Zimmer Biomet Holdings, Inc.:(NYSE:ZBH) performed recently?

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a large market cap stock with a market cap of 25346.21. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 524.46, a forward P/E of 14.87 and EPS of 0.25. At a stock price of 130.48 (-0.08%) it has a dividend yield of 0.74%.

EPS growth for the last five years have been -23.60%, more recently this last year it has grown by -81.50%. The next year growth is going to be about 10.27% and more long-term 11.17% after five years. EPS growth quarter over quarter is *TBA. Sales growth for the past five years have been 7.30% and sales growth quarter over quarter is -44.30%.

For performance, Zimmer Biomet Holdings, Inc. the past week has seen a gain of 5.64%. For the last month performance for Zimmer Biomet Holdings, Inc. is 8.21%. While the last quarter is 13.89% and half year, 33.78%. Finally for the year, performance is 26.28%.

The 52-week high for Zimmer Biomet Holdings, Inc., is at -0.83%, and for the 52-week low it comes to a value of 48.46%. The 20-day simple moving average is 7.07% and 20.72% for the 200-day simple moving average.

Volatility for the week is at 1.97%, and for the month it is 1.46%. Zimmer Biomet Holdings, Inc., has a target price of 135.9.

In terms of debt, long term debt/equity is *TBA, and for total debt/equity Zimmer Biomet Holdings, Inc. has *TBA. The gross margin is 69.60%, while operating margin is 11.50%, the profit margin is *TBA. The current ratio is *TBA and the quick ratio is *TBA.

Insider ownership is at 0.20%, with instituitional ownership at 90.00%. Zimmer Biomet Holdings, Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 194.09. The shares float is 194.09, with the float short at 3.02%, with short ratio coming to 3.67.

In terms of returns, the return on assets see Zimmer Biomet Holdings, Inc., get *TBA, with its returns on investment at 2.10%. Return on equity is *TBA. So will the investors see the target price of 135.9, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment